These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6071552)

  • 1. Abnormal thyrotropic substance in the pituitaries of patients with Graves' disease.
    Kumahara Y; Iwatsubo H; Miyai K; Masui H; Fukuchi M; Abe H
    J Clin Endocrinol Metab; 1967 Mar; 27(3):333-40. PubMed ID: 6071552
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyrotropin in human fetal pituitaries.
    Fukuchi M; Inoue T; Abe H; Kumahara Y
    J Clin Endocrinol Metab; 1970 Nov; 31(5):565-9. PubMed ID: 5528389
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of TRF in the study of pituitary reserve of TSH].
    Cantalamessa L; Reschini E; Giustina G; Miedico D; Valentini F; Beretta F
    Folia Endocrinol; 1973 Feb; 26(1):57-70. PubMed ID: 4633898
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between thyrotropin concentration and cell morphology of anterior pituitary in asymptomatic atrophic thyroiditis.
    Bonnyns M; Pasteels JL; Herlant M; Vanhaelst L; Bastenie PA
    J Clin Endocrinol Metab; 1972 Nov; 35(5):722-8. PubMed ID: 5071342
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoassay studies of thyrotropin in rat pituitary glands and serum.
    Wilber JF; Utiger RD
    Endocrinology; 1967 Jul; 81(1):145-51. PubMed ID: 6028861
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitization of T-lymphocytes in Graves' and Hashimoto's diseases.
    Okita N; Kidd A; Row VV; Volpé R
    J Clin Endocrinol Metab; 1980 Aug; 51(2):316-20. PubMed ID: 6249836
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability of thyrotropin in the rat pituitary gland after death.
    Hershman JM
    Endocrinology; 1967 Feb; 80(2):302-4. PubMed ID: 6017871
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyrotropin from amphibian (Rana catesbeiana) pituitaries and evidence for heterothyrotropic activity of bullfrog luteinizing hormone in reptiles.
    MacKenzie DS; Licht P; Papkoff H
    Gen Comp Endocrinol; 1978 Dec; 36(4):566-74. PubMed ID: 220138
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification of thyrotropin from the pituitaries of two turtles: the green sea turtle and the snapping turtle.
    MacKenzie DS; Licht P; Papkoff H
    Gen Comp Endocrinol; 1981 Sep; 45(1):39-48. PubMed ID: 7286628
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of TSH on the 24-hr 131-I uptake in Graves' disease.
    Charkes ND
    J Nucl Med; 1969 May; 10(5):246-8. PubMed ID: 4181519
    [No Abstract]   [Full Text] [Related]  

  • 11. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune-resistance in Graves' disease tissues indication of a structural and functional heterogenicity.
    Müller-Gärtner HW; Schneider C; Schröder S
    Acta Endocrinol (Copenh); 1986 Oct; 113(2):233-41. PubMed ID: 3535326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
    Gupta MK
    Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytochemical bioassay for thyroid -stimulating antibody of Graves' disease: further experience.
    Loveridge N; Zakarija M; Bitensky L; McKenzie JM
    J Clin Endocrinol Metab; 1979 Oct; 49(4):610-5. PubMed ID: 582599
    [No Abstract]   [Full Text] [Related]  

  • 18. Concepts of pathogenesis of Graves' disease.
    Solomon DH; Kleeman KE
    Adv Intern Med; 1977; 22():273-99. PubMed ID: 402796
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of serum TSH by Graves' Ig: evidence for a functional pituitary TSH receptor.
    Brokken LJ; Scheenhart JW; Wiersinga WM; Prummel MF
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4814-7. PubMed ID: 11600546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.